Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
As a result of the investment in cancer research, NCI was in a strong position to make key early advances in the fight against HIV/AIDS.
Treatments that help the immune system fight cancer have revolutionized cancer care.
HIV-positive people with AIDS-defining cancers had increased epigenetic age compared with HIV-negative people with similar types of cancer.
However, lung cancer incidence among HIV-positive people has fallen over the past two decades.
Researchers from around the globe gathered to discuss the virus that causes Kaposi sarcoma.
Long-term HIV survivor and author Vishwas Pethe shares his secrets to happiness.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related Kaposi sarcoma.
I was one of those physicians providing care to gay men in New York City when AIDS first came to attention.
The immune modulator Pomalyst led to remission in two thirds of people with AIDS-related KS.
Long-term survivor John Reams shared his story of profound loss and immense gratitude.
Peer support is more important than ever.
POZ asked readers: How did HIV change your life? A long-term survivor shares his story of profound loss and immense gratitude.
Study suggests immune-based cancer therapies might be particularly beneficial for HIV-positive people.
Researchers analyzed autopsies among people with HIV who died in New York City since 1984.
The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.